China makes progress in developing vaccines against Omicron variant


Тимофей Борзенко

A medical worker prepares a dose of COVID-19 vaccine at a vaccination site in Beijing, capital of China. Photo by Xinhua/Zhang Yuwei.

Positive progress has been made in the development of monovalent and multivalent vaccines against Omicron variants, a senior Chinese health official told a press conference. This was reported by Xinhua News Agency.

“Preclinical studies of some vaccines have been completed, with applications for clinical trials underway”, – said Zheng Zhongwei, an official with the National Health Commission.

“Studies show that the Omicron variant has not completely escaped existing vaccines,” – said Zheng, noting that full vaccination is still effective in reducing the risk of hospitalization, serious illness and death caused by Omicron variants.

“Booster vaccination can also effectively reduce the risk of breakthrough infection caused by the Omicron variant”, – he said.

“At present, China has 29 vaccines that have entered clinical trials, including 16 in phase III clinical trials overseas,” – Zheng said. He added that “seven vaccines have been approved for conditional marketing or emergency use, and two have been included in the World Health Organization’s emergency use list”.


Comments are closed.